Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01006369
Title Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications

colorectal cancer

Therapies

Hydroxychloroquine

Bevacizumab + Capecitabine + Oxaliplatin

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.